Does BARICITINIB Cause Hepatitis b reactivation? 8 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hepatitis b reactivation have been filed in association with BARICITINIB (Olumiant). This represents 0.1% of all adverse event reports for BARICITINIB.
8
Reports of Hepatitis b reactivation with BARICITINIB
0.1%
of all BARICITINIB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Hepatitis b reactivation From BARICITINIB?
Of the 8 reports, 1 (12.5%) resulted in death, 2 (25.0%) required hospitalization.
Is Hepatitis b reactivation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BARICITINIB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does BARICITINIB Cause?
Drug ineffective (569)
Off label use (479)
Covid-19 (347)
Pulmonary embolism (288)
Rheumatoid arthritis (284)
Headache (216)
Herpes zoster (216)
Pneumonia (216)
Death (206)
Deep vein thrombosis (201)
What Other Drugs Cause Hepatitis b reactivation?
RITUXIMAB (914)
CYCLOPHOSPHAMIDE (801)
DOXORUBICIN (684)
VINCRISTINE (641)
PREDNISONE (583)
PREDNISOLONE (465)
LAMIVUDINE (308)
METHOTREXATE (305)
DEXAMETHASONE (293)
ETOPOSIDE (213)
Which BARICITINIB Alternatives Have Lower Hepatitis b reactivation Risk?
BARICITINIB vs BARIUM
BARICITINIB vs BARNIDIPINE
BARICITINIB vs BASILIXIMAB
BARICITINIB vs BAYER GENUINE ASPIRIN ORIGINAL STRENGTH
BARICITINIB vs BAZEDOXIFENE\ESTROGENS, CONJUGATED